Development of a Prognostic Survival Risk Score for Lung Cancer Patients With Type 2 Diabetes Mellitus: A Territory‐Wide Retrospective Cohort Study
Cancer Medicine · 2026
DOI: 10.1002/cam4.72164 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancer Medicine, 2026. Verfasst von Claire Chenwen Zhong und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Lung Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus, Onkologische Pflege
Abstract (Originalsprache)
Background
Lung cancer is a leading cause of cancer‐related mortality, and its prognosis is often affected by comorbidities such as type 2 diabetes mellitus (T2DM). This study aimed to identify survival risk factors for lung cancer patients with T2DM, evaluate the predictive models, and develop a risk score system for survival prediction. Study Design and Methods We analyzed data from 5491 lung cancer patients with T2DM from the Hong Kong Hospital Authority Data Collaboration Laboratory (HADCL) (2000–2020). Prognostic factors were evaluated using Cox proportional hazards regression. Four algorithms were used to construct survival analysis models: Cox proportional hazards regression, LASSO Cox regression, survival tree, and random survival forests (RSF). An interpretable risk scoring system was subsequently derived using the selected predictors.
Results
Older age at cancer diagnosis, male sex, longer duration between T2DM diagnosis and lung cancer diagnosis (T2DM duration), smoking, alcohol consumption, history of stroke, and higher HbA1c were associated with increased mortality risk, whereas hypertension, coronary heart disease, insulin usage, anti‐lipid usage, and anti‐diabetic usage were associated with reduced mortality risk. Among the evaluated models, the RSF model demonstrated the best predictive performance, as indicated by the C‐index (0.71) and time‐dependent AUC (0.883). The developed risk score system included the following criteria: age at cancer diagnosis; T2DM duration; smoking status; HbA1c; HDL‐C; serum potassium (K) levels; LDL‐C. A score ≥ 75 classified 47.33% of patients as high‐risk, with a corresponding five‐year survival probability of 5.51%.
Conclusions
Among the evaluated models, the RSF model demonstrated the best predictive performance. The developed risk scoring system may support risk stratification and identification of high‐risk patient subgroups, potentially facilitating personalized prognostic assessment and clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Centre for Health Education and Health Promotion, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Clinical Research Center & Big Data Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
- State Key Laboratory of Oncology in South China, Department of Radiation Oncology, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
- Institute of Robotics and Automatic Information Systems, College of Artificial Intelligence, Nankai University, Tianjin, China.
- Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
ORCID-Profile: Claire Chenwen Zhong, Junjie Huang, Yu Jiang, Xiaofang Liu, Han Wang, Arthur Sung, Martin C S Wong
Zitieren
APA
Zhong, C. C., Huang, J., Li, Z., Jiang, Y., Yang, Z., Yuan, J., Huang, X., Liu, X., Wang, H., Poon, J., Dou, Q., Sung, A., & Wong, M. C. S. (2026). Development of a Prognostic Survival Risk Score for Lung Cancer Patients With Type 2 Diabetes Mellitus: A Territory‐Wide Retrospective Cohort Study. Cancer Medicine. https://doi.org/10.1002/cam4.72164
Vancouver
Zhong CC, Huang J, Li Z, Jiang Y, Yang Z, Yuan J, et al. Development of a Prognostic Survival Risk Score for Lung Cancer Patients With Type 2 Diabetes Mellitus: A Territory‐Wide Retrospective Cohort Study. Cancer Medicine. 2026. doi:10.1002/cam4.72164
BibTeX
@article{Zhong2026,
author = {Zhong, Claire Chenwen and Huang, Junjie and Li, Zhaojun and Jiang, Yu and Yang, Zehuan and Yuan, Jinqiu and Huang, Xiaodan and Liu, Xiaofang and Wang, Han and Poon, Jonathan and Dou, Qi and Sung, Arthur and Wong, Martin C S},
title = {Development of a Prognostic Survival Risk Score for Lung Cancer Patients With Type 2 Diabetes Mellitus: A Territory‐Wide Retrospective Cohort Study},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72164}
}
EUVIMED